NIH-funded research R21 grant

Probiotic platform to gently tune your gut environment

Official title: A Probiotic Platform for Autonomous Modulation of Gut Environment

Funded at Texas Engineering Experiment Station · NIH-11374377 · Data updated 2026-11-12

A safe, patient-friendly approach aims to use engineered beneficial bacteria to improve gut health by boosting helpful metabolites and improving gut barrier function.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startSeptember 7, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$142,616
NIH project number1R21EB037833-01A1
Project IDNIH-11374377 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with gut health issues linked to imbalanced microbiome and low fiber tolerance who might benefit from microbiome-directed therapies.

Less likely to help

People without gut microbiome imbalances or those who cannot tolerate any live bacterial therapies may see limited or no benefit.

What this research studies

This project plans to create a tiny, living therapy that lives in the gut and can adjust itself based on what the gut needs. It focuses on improving compounds that support gut health and might help people whose gut bacteria don’t work optimally. The work involves designing a smart bacterial system that responds to local signals to increase beneficial SCFAs and stay in the gut longer. Researchers will test the platform in a controlled setting to ensure it can safely regulate its activity without causing harm. The goal is a future option that could supplement fiber and improve gut-related health conditions.

Why it matters

Potential benefit: If successful, it could lead to a new way to support gut health by modulating microbial activity.

How similar studies have gone: Previous work shows promise for engineered probiotic approaches, but this platform's autonomous regulation is a novel step.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Hu, Chelsea — Texas Engineering Experiment Station
  • Study coordinator: Hu, Chelsea

Related research

Other NIH-funded projects on the same topics.

  • Robotic dental implants to deliver stem cells

    A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11591543

  • Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis

    A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11577865

  • Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk

    This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11456681

  • Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones

    A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11449053

  • Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer

    Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448647

  • Targeted nanoparticle therapy for lung fibrosis

    A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448075

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.